Belite Bio, Inc (BLTE) stock
BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
$164.35−5.61 (-3.30%)
Close on Nov 13, 2026Market cap $6.47BP/E –Yield –
Belite Bio cash
Cash and short-term investments held at the end of each period.
Belite Bio's cash was $352.93M at Dec 31, 2025. For fiscal 2025 it was $352.93M, up 874.3% from the year before. The highest annual figure on record is $352.93M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $352.93M | +874.3% |
| FY2024 | Dec 31, 2024 | $36.23M | -58.9% |
| FY2023 | Dec 31, 2023 | $88.16M | +109.5% |
| FY2022 | Dec 31, 2022 | $42.09M | +142.7% |
| FY2021 | Dec 31, 2021 | $17.34M | -32.3% |
| FY2020 | Dec 31, 2020 | $25.62M | +1170.1% |
| FY2019 | Dec 31, 2019 | $2.02M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $352.93M | +1934.9% |
| Q4 FY2024 | Dec 31, 2024 | $36.23M | +41.4% |
| Q4 FY2023 | Dec 31, 2023 | $88.16M | +4270.7% |
| Q4 FY2022 | Dec 31, 2022 | $42.09M | – |
| Q4 FY2021 | Dec 31, 2021 | $17.34M | – |
| Q4 FY2020 | Dec 31, 2020 | $25.62M | – |
| Q4 FY2019 | Dec 31, 2019 | $2.02M | – |
See a number that looks wrong?